Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)

Blood - Tập 107 - Trang 349-354 - 2006
Achille Iolascon, Maria d'Apolito, Veronica Servedio, Flora Cimmino, Antonio Piga, Clara Camaschella

Tóm tắt

Abstract

Divalent metal transporter 1 (DMT1) mediates apical iron uptake in duodenal enterocytes and iron transfer from the transferrin receptor endosomal cycle into the cytosol in erythroid cells. Both mk mice and Belgrade rats, which carry an identical DMT1 mutation, exhibit severe microcytic anemia at birth and defective intestinal iron use and erythroid iron use. We report the hematologic phenotype of a child, compound heterozygote for 2 DMT1 mutations, who was affected by severe anemia since birth and showed hepatic iron overload. The novel mutations were a 3-bp deletion in intron 4 (c.310-3_5del CTT) resulting in a splicing abnormality and a C>T transition at nucleotide 1246(p. R416C). A striking reduction of DMT1 protein in peripheral blood mononuclear cells was demonstrated by Western blot analysis. The proband required blood transfusions until erythropoietin treatment allowed transfusion independence when hemoglobin levels between 75 and 95 g/L (7.5 and 9.5 g/dL) were achieved. Hematologic data of this patient at birth and in the first years of life strengthen the essential role of DMT1 in erythropoiesis. The early onset of iron overload indicates that, as in animal models, DMT1 is dispensable for liver iron uptake, whereas its deficiency in the gut is likely bypassed by the up-regulation of other pathways of iron use.


Tài liệu tham khảo

Fleming MD, Trenor CC, Su MA, et al. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997;16: 383-386. Fleming MD, Romano MA, Su MA, Garrick LM, Andrews NC. Nramp2 is mutated in the anemic Begrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A. 1998;95: 1148-1153. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388: 482-487. Cannone-Hergaux S, Gruenheid S, Ponka P, Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood. 1999;93: 4406-4417. Su M, Trenor CC, Fleming JC, Fleming MD, Andrews NC. The G185R mutation disrupts function of the iron transporter Nramp2. Blood. 1998;92: 2157-2163. Touret N, Martin-Orozco N, Paroutis P, et al. Molecular and cellular mechanisms underlying iron transport deficiency in microcytic anemia. Blood. 2004;104: 1526-1533 Cannone-Hergaux S, Zhang AS, Ponka P, Gros P. Characterization of the iron transporter DMT1 (Nramp2/DCT1) in red blood cells of normal and anaemic mk/mk mice. Blood. 2001;98: 3823-3830. Priwitzerova M, Pospisilova D, Prchal JT, et al. Severe hypochromic microcytic anemia caused by a congenital defect of the iron transporter pathway in erythroid cells. Blood. 2004;103: 3991-3992. Mims MP, Guan Y, Pospisilova D, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood. 2005;105: 1337-1342. Tchernia G, Delhommeau F, Perrotta S, et al. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. Hematol J. 2000;1: 146-152. Fischer R. Liver iron susceptometry. In: Andrae W, Nowak H, eds. Magnetism in Medicine—a Handbook. Berlin, Germany: Wiley-VHC; 1998: 286-301. Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med. 1982;307: 1671-1675. Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000; 343: 327-331. Sciot R, van Eyken P, Facchetti F, et al. Hepato-cellular transferrin receptor expression in secondary siderosis. Liver. 1989;9: 52-61. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989. Levy JE, Jin O, Fujiwara Y, et al. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999; 21: 396-399. Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood. 2002;100: 2040-2045. Lee PL, Gelbart T, West C, Halloran C, Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis. 1998;24: 199-215. Priwitzerova M, Pospsilova D, Sheftel AD, Dikovy V, Ponka P. Functional consequences of the human DMT1 mutation on protein expression and iron uptake. Presented at: BioIron 2005: First Congress of the International BioIron Society; May 22-26, 2005; Prague, Czech Republic. Abstract 126. Carteggi L, Chew S, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3: 285-298. Gunshin H, Fujiwara Y, Custodio AO, Direnzo C, Robine S, Andrews N. SLC11A2 is required for intestinal absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005;115: 1258-1266. Priwitzerova M, Pospisilova D, Indrak K, Ponka P, Divoky V. Consequences of DMT1 mutation on proliferation and hemoglobinization of erythroid progenitors in vitro [abstract]. Blood. 2004;104: 3190.
Thông tin
Thông tin xuất bản

Blood

Tập 107

349-354

Thông tin tác giả